VVOS · Vivos Therapeutics, Inc. · Analyst Estimates
$0.18
+0.01 (+6.70%)
At close · Sep 10
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had approximately $1.8 million in cash and cash equivalents, which will not be sufficient to fund operations and strategic objectives over the next twelve months from the date of the issuance of these financial statements. Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.42M
Shares
20.12M
Analyst Estimates
Compare analyst forecasts for Vivos Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1716166
CUSIP
92859E207
13F (30d)
11 filings
11 filers
Visit website
Investor relations